David
Santamaría Velilla
University of Liège
Lieja, BélgicaPublicacións en colaboración con investigadores/as de University of Liège (4)
2024
-
In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAFV600E lung adenocarcinoma
Cell Reports Medicine, Vol. 5, Núm. 8
-
RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade
Nature Communications, Vol. 15, Núm. 1
2020
-
Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma
JCI Insight, Vol. 5, Núm. 15
2011
-
Cdk6-dependent regulation of G1 length controls adult neurogenesis
Stem Cells, Vol. 29, Núm. 4, pp. 713-724